Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases

DNA vaccines are considered as a third-generation vaccination approach in which antigenic materials are encoded as DNA plasmids for direct in vivo production to elicit adaptive immunity. As compared to other platforms, DNA vaccination is considered to have a strong safety profile, as DNA plasmids ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ziyang, Patel, Ami, Tursi, Nicholas J., Zhu, Xizhou, Muthumani, Kar, Kulp, Daniel W., Weiner, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757735/
https://www.ncbi.nlm.nih.gov/pubmed/35047878
http://dx.doi.org/10.3389/fmedt.2020.571030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757735/
https://www.ncbi.nlm.nih.gov/pubmed/35047878
http://dx.doi.org/10.3389/fmedt.2020.571030

Ejemplares similares